VST-BIO Announces Successful Preclinical Trials in Ischemic Stroke
VST-Bio’s Collaborators Present Preclinical Trial Results at the American Heart Association International Stroke Conference in Dallas. SAN DIEGO, Feb. 10, 2023 /PRNewswire/ — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiovascular…
Comments Off on VST-BIO Announces Successful Preclinical Trials in Ischemic Stroke